Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma, Follicular 2Psoriasis 1Plaque, Amyloid 1Dermatitis, Atopic 1

Interventions

Rituximab 130Cyclophosphamide 113Peripheral Blood Stem Cell Transplantation 59fludarabine phosphate 55Etoposide 47Mycophenolic Acid 44Radiotherapy 41Filgrastim 41Tacrolimus 40Whole-Body Irradiation 36Busulfan 34Melphalan 33Cyclosporine 30Cytarabine 29Methotrexate 28sargramostim 27Vincristine 27Antilymphocyte Serum 27Prednisone 26Lenalidomide 23obinutuzumab 22Doxorubicin 22Carmustine 21Bortezomib 20Methylprednisolone 19fludarabine 17Dexamethasone 17Bendamustine Hydrochloride 17ibritumomab tiuxetan 15Cord Blood Stem Cell Transplantation 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma, Follicular × abrocitinib × Clear all
NCT02780167 2019-05-02

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

Pfizer

Phase 2 Completed
269 enrolled 31 charts
Lymphoid

Dermatitis, Atopic, Lymphoma, Follicular

NCT02201524 2016-10-05

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Pfizer

Phase 2 Terminated
59 enrolled 18 charts
Lymphoid

Lymphoma, Follicular, Psoriasis, Plaque, Amyloid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡